ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

Pitt Seeks Biostatistician For NSABP, Hearing Delayed a Week

September 23, 1994

Patient Advocacy: Breast Cancer Coalition Forms PAC To Increase Political Activities

April 18, 1997

Senate Orders OMB T Increase NIH FTEs, Drop Rules On Apportionment

September 19, 1986

Mihich Subcommittee Recommendations For Augmenting Agents In BRMP Described

December 7, 1979

Funding NCI Bypass Budget The “Very Least” Congress Could Do, Congressman Durbin Says

July 13, 1990

Comprehensive Centers Could Lose That Designation By Not Producing

May 30, 1975